Takeda Pharmaceutical
TAK
#512
Rank
A$70.39 B
Marketcap
A$22.28
Share price
1.36%
Change (1 day)
-2.76%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): A$4.93 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.86 Billion. , an increase over its 2024 earnings that were of A$3.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 A$4.74 B49.03%
2024 A$3.18 B-2.41%
2023 A$3.25 B-28.14%
2022 A$4.53 B-40.9%
2021 A$7.67 B78.24%
2020 A$4.30 B246.1%
2019 A$1.24 B-48.79%
2018 A$2.42 B-23.64%
2017 A$3.18 B21.7%
2016 A$2.61 B-253.01%
2015 -A$1.71 Billion-159.65%
2014 A$2.86 B13%
2013 A$2.53 B2.46%
2012 A$2.47 B-57.05%
2011 A$5.75 B-10.49%
2010 A$6.43 B-3.99%
2009 A$6.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.03 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.49 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.09 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.95 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.91 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$18.74 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.27 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.13 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.24 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India